Vercise™ DBS Dystonia Prospective Study
ConditionDystonia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorBoston Scientific Corporation
About this trial
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Eligibility criteria
Qualifiers
IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia.
IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.
Disqualifiers
EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use.
Trial design
Treatments tested in this trial
- Deep Brain Stimulation (DBS)
Treatment groups
No treatment groups listed
Locations
36Belgium
AZ Sint-Lucas Ghent Belgium
UZ Gasthuisberg Leuven Belgium
Canada
Queen Elizabeth II Health Sciences Center Halifax Canada
Germany
University Berlin, Charite Virchow Standort, Wedding Berlin Germany
Sponsors and collaborators
Boston Scientific Corporation
Lead sponsor
Source ClinicalTrials.gov